HSBC Upgrade Sends Merck KGaA Stock Soaring
Merck KGaA stock rose by 1.7% to reach €141.30 during today's session, driven by HSBC's upgrade of its rating from Hold to Buy.
Analysts at HSBC cited three key factors for the upgrade: attractive valuation, strong growth in the first half of 2026, and the stock's underperformance relative to peers despite improving fundamentals.
The second-quarter 2026 results released in early August showed organic sales growth accelerating to 4.1% from 2.9% in the first quarter, with Life Science Process Solutions expanding by 15% organically.
The Life Science and Electronics divisions have been driving this growth, reinforcing the bull case presented by HSBC.